{"transactions":[{"id":1131877,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-28T17:52:32.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":876,"price":1.67,"value":1462.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 876 shares of Class A Common Stock was exempt pursuant to Rule 16b-3."}],"balance_after":674636,"source":{"system":"sec-edgar","filing":"0001823239-25-000069","document":"wk-form4_1748469145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323925000069/wk-form4_1748469145.xml","form_type":"4"}},{"id":1197122,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-19T17:58:30.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":394478,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of March 15, 2026, March 15, 2027, and March 15, 2028, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":673760,"source":{"system":"sec-edgar","filing":"0001823239-25-000056","document":"wk-form4_1742421504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323925000056/wk-form4_1742421504.xml","form_type":"4"}},{"id":1197121,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-19T17:27:14.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":8648,"price":2.64,"value":22830.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":279282,"source":{"system":"sec-edgar","filing":"0001823239-25-000044","document":"wk-form4_1742419628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323925000044/wk-form4_1742419628.xml","form_type":"4"}},{"id":1259965,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-19T16:44:53.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2326,"price":4.1,"value":9536.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":287930,"source":{"system":"sec-edgar","filing":"0001823239-25-000022","document":"wk-form4_1740001486.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323925000022/wk-form4_1740001486.xml","form_type":"4"}},{"id":1300130,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-17T16:19:20.000Z","date":"2025-01-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":46344,"price":4.56,"value":211328.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":290256,"source":{"system":"sec-edgar","filing":"0001823239-25-000015","document":"wk-form4_1737148752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323925000015/wk-form4_1737148752.xml","form_type":"4"}},{"id":1368986,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-12T17:18:15.000Z","date":"2024-10-31","kind":"grant","planned":false,"acquired":true,"shares":1906,"price":5.7,"value":10864.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,906 shares of Class A Common Stock was exempt pursuant to Rule 16b-3."}],"balance_after":336600,"source":{"system":"sec-edgar","filing":"0001823239-24-000117","document":"wk-form4_1731449889.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323924000117/wk-form4_1731449889.xml","form_type":"4"}},{"id":1530585,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-02T18:46:36.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":1780,"price":5.7,"value":10146.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,780 shares of Class A Common Stock was exempt pursuant to Rule 16b-3."}],"balance_after":334694,"source":{"system":"sec-edgar","filing":"0001823239-24-000055","document":"wk-form4_1714689986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323924000055/wk-form4_1714689986.xml","form_type":"4"}},{"id":1572377,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-18T17:55:29.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8624,"price":7.7,"value":66404.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":332914,"source":{"system":"sec-edgar","filing":"0001823239-24-000036","document":"wk-form4_1710798913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323924000036/wk-form4_1710798913.xml","form_type":"4"}},{"id":1633760,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-20T18:47:02.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2664,"price":5.48,"value":14598.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":341538,"source":{"system":"sec-edgar","filing":"0001823239-24-000025","document":"wk-form4_1708472810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323924000025/wk-form4_1708472810.xml","form_type":"4"}},{"id":1676411,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T18:26:14.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":250277,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") awarded  under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":344202,"source":{"system":"sec-edgar","filing":"0001823239-24-000010","document":"wk-form4_1705620365.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323924000010/wk-form4_1705620365.xml","form_type":"4"}},{"id":1739084,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-16T17:22:09.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":1861,"price":5.83,"value":10849.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,861 shares of Class A Common Stock was exempt pursuant to Rule 16b-3."}],"balance_after":93925,"source":{"system":"sec-edgar","filing":"0001823239-23-000096","document":"wk-form4_1700173315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323923000096/wk-form4_1700173315.xml","form_type":"4"}},{"id":1826882,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-19T16:51:43.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":874,"price":11.72,"value":10243.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 874 shares of Class A Common Stock was exempt pursuant to Rule 16b-3."}],"balance_after":92064,"source":{"system":"sec-edgar","filing":"0001823239-23-000068","document":"wf-form4_168979989281869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323923000068/wf-form4_168979989281869.xml","form_type":"4"}},{"id":1947036,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-17T16:52:09.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":143000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on April 15, 2023 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":143000,"derivative":{"exercise_price":15.52,"expiration_date":"2033-03-15","underlying":"Class A Common Stock","underlying_shares":143000},"source":{"system":"sec-edgar","filing":"0001823239-23-000028","document":"wf-form4_167908631546730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323923000028/wf-form4_167908631546730.xml","form_type":"4"}},{"id":1947035,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-17T16:52:09.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":72507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") awarded  under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of March 15, 2024, March 15, 2025, and March 15, 2026, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":91190,"source":{"system":"sec-edgar","filing":"0001823239-23-000028","document":"wf-form4_167908631546730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323923000028/wf-form4_167908631546730.xml","form_type":"4"}},{"id":2007670,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T16:32:54.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":2611,"price":15.23,"value":39765.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person."}],"balance_after":18683,"source":{"system":"sec-edgar","filing":"0001823239-23-000007","document":"wf-form4_167666953300244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323923000007/wf-form4_167666953300244.xml","form_type":"4"}},{"id":2121184,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-09T17:35:47.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":478,"price":14.11,"value":6744.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 478 shares of Class A Common Stock was exempt pursuant to Rule 16b-3."}],"balance_after":21294,"source":{"system":"sec-edgar","filing":"0001823239-22-000063","document":"wf-form4_166803332873857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323922000063/wf-form4_166803332873857.xml","form_type":"4"}},{"id":2221142,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-06-27T19:55:18.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":427,"price":22.95,"value":9799.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Amended to note that this is a voluntary filing. The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 427 shares of Class A Common Stock was exempt pursuant to Rule 16b-3."}],"balance_after":20816,"source":{"system":"sec-edgar","filing":"0001823239-22-000032","document":"wf-form4a_165637410200444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323922000032/wf-form4a_165637410200444.xml","form_type":"4/A","original_submission_date":"2022-06-27"}},{"id":2221140,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-06-27T18:42:28.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":427,"price":22.95,"value":9799.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 427 shares of Class A Common Stock was exempt pursuant to Rule 16b-3."}],"balance_after":20816,"source":{"system":"sec-edgar","filing":"0001823239-22-000026","document":"wf-form4_165636973465957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000182323922000026/wf-form4_165636973465957.xml","form_type":"4"}},{"id":2424057,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-27T16:00:30.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":36200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":36200,"derivative":{"exercise_price":26.32,"expiration_date":"2032-01-25","underlying":"Class A Common Stock","underlying_shares":36200},"source":{"system":"sec-edgar","filing":"0000899243-22-003418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000089924322003418/doc4.xml","form_type":"4"}},{"id":2424056,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-27T16:00:30.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":19500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents restricted stock units (\"RSUs\") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the reporting person's continued employment with the Issuer."}],"balance_after":20389,"source":{"system":"sec-edgar","filing":"0000899243-22-003418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000089924322003418/doc4.xml","form_type":"4"}},{"id":2424055,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-27T16:00:30.000Z","date":"2021-10-31","kind":"grant","acquired":true,"shares":392,"price":22.95,"value":8996.4,"ownership":{"direct":true},"footnotes":[{"field":"timeliness","element":"transactionTimeliness","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 889 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c)."}],"balance_after":889,"source":{"system":"sec-edgar","filing":"0000899243-22-003418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000089924322003418/doc4.xml","form_type":"4"}},{"id":2424054,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-27T16:00:30.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":497,"price":22.95,"value":11406.15,"ownership":{"direct":true},"footnotes":[{"field":"timeliness","element":"transactionTimeliness","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 889 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c)."}],"balance_after":497,"source":{"system":"sec-edgar","filing":"0000899243-22-003418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000089924322003418/doc4.xml","form_type":"4"}},{"id":2969916,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-11-23T17:32:11.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":60000,"derivative":{"exercise_price":27,"expiration_date":"2030-11-19","underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-20-031947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671595/000089924320031947/doc4.xml","form_type":"4"}},{"id":4469967,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":79172,"kind":"person","name":"Herde Kevin","position":1,"cik":"0001671595","reported_name":"Herde Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP and CFO"}}],"security":"Common Stock","published_at":"2017-02-03T19:48:23.000Z","date":"2017-02-03","kind":"purchase","acquired":true,"shares":3000,"price":5.15,"value":15450.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000899243-17-002785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924317002785/doc4.xml","form_type":"4"}}]}